暖羊羊Y
Lv43
490 积分
2024-07-23 加入
-
Update on Newly FDA-Approved Drug, Resmetirom: A Practical Perspective
2个月前
已完结
-
LBP-045 Efficacy and safety of HSK31679, a thyroid hormone receptor β agonist, for the treatment of asian non-alcoholic fatty liver disease: a multicenter randomized, double-blind, placebo-controlled, phase 2a trial
2个月前
已完结
-
LBP-045 Efficacy and safety of HSK31679, a thyroid hormone receptor β agonist, for the treatment of asian non-alcoholic fatty liver disease: a multicenter randomized, double-blind, placebo-controlled, phase 2a trial
2个月前
已完结
-
Resmetirom proves positive for NASH with liver fibrosis
2个月前
已完结
-
Resmetirom for MASH-related cirrhosis
2个月前
已完结
-
Resmetirom for treatment of MASH
2个月前
已完结